What is the market price of a box of Avatrombopag tablets/Sukesin?

Avatrombopag is an oral thrombopoietin receptor agonist that has been approved for marketing in mainland China and has entered the category of Class B drugs in the National Reimbursement Catalog. It is suitable for the treatment of thrombocytopenia associated with elective surgery for chronic liver disease and chronic immune thrombocytopenia (ITP) and other diseases. According to the national medical insurance policy, Su Kexin’s medical insurance reimbursement is applicable to patients with specific diagnosis and qualifications, and must be used under the guidance of a doctor and reimbursed through reasonable medical treatment paths. In the absence of medical insurance reimbursement, patients need to purchase the drug at their own expense. Common specifications on the market are 20 mg 10 tablets or 20 mg 15 tablets. The price per box is about 6,000 to 7,000 yuan. The price may fluctuate slightly depending on the channel, region, hospital or pharmacy purchasing method.

In contrast, the original drug price of avatrombopag in overseas markets is generally higher, especially in countries and regions such as the United States and the European Union, where the price of a box of the same specifications may be several times higher than the domestic price. In addition to the original drug, some overseas countries and regions have allowed generic drugs of avatrombopag to enter the market. These generic drugs are basically the same as the original drug in terms of drug ingredients, bioavailability and clinical effects. However, due to the lack of brand premium and patent protection, the selling price is much lower than the original drug. According to public channels, for example, the generic version of avatrombopag produced by some pharmaceutical companies in Laos has a specification of 20mg*30 tablets and sells for about more than 400 yuan per box. The price advantage is very obvious.

However, it should be noted that if patients choose generic drugs, they should carefully check the formality and legality of the source of the drugs to avoid purchasing fake drugs or inferior products. On the premise of equivalent efficacy, generic drugs provide patients with more economical medication options, especially suitable for long-term drug users to reduce their financial burden. In summary, although Su Kexin is expensive in China, it has been included in the scope of medical insurance reimbursement; while the generic version has a certain cost-effectiveness overseas and is suitable for patients who have access to drugs to consider using it.

Reference materials:https://go.drugbank.com/drugs/DB11995